Ursprung des Netzwerks ersten Grades von Thomas N. Sato
| Einheit | Art der Einheit | Industrie | |
|---|---|---|---|
Karydo TherapeutiX, Inc.
 Karydo TherapeutiX, Inc. Miscellaneous Commercial ServicesCommercial Services Karydo TherapeutiX, Inc. develops technologies to detect the earliest signs of diseases. Its proprietary technology includes “iOrgans Technology.” This technology consists of three sub-technologies: Reverse-iOrgans (R-iOrgans,) Forward-iOrgans (F-iOrgans) and Drug-iOrgans (D-iOrgans.) They all use iOrgans Indicators (iOrgans-Id) to effectively and efficiently detect the earliest signs of diseases (R-iOrgans,) and to pre-empt them (F-iOrgans.) This technology can be also used to discover effects of drugs (D-iOrgans.) The company was founded by Thomas Sato on October 15, 2015 and is headquartered in Tokyo, Japan.
3
| Holding Company | Miscellaneous Commercial Services | 3 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von Thomas N. Sato
| Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
|---|---|---|---|
| TELLA, INC. | Biotechnology | Director/Board Member | |
| Allgene, Inc. | Director/Board Member | ||
Biomedica Solution KK
 Biomedica Solution KK BiotechnologyHealth Technology Part of Tella, Inc., Biomedica Solution KK is a Japanese company that manufactures cell production facilities. | Biotechnology | Director/Board Member |
Statistik
International
| Japan | 4 |
Sektoral
| Health Technology | 3 |
Operativ
| Director/Board Member | 6 |
| Sales & Marketing | 1 |
Am stärksten vernetzte Beziehungen
| Insiders | |
|---|---|
| Takehide Iwasa | 4 |
| Keiko Sugisaka | 1 |
| Hisashi Mitsuguchi | 1 |
- Börse
- Insiders
- Thomas N. Sato
- Unternehmensverbindungen
